Another Brand Of Infant Formula Recalled After Botulism Cases

Another infant formula has been linked to cases of botulism in infants and subject to an immediate CDC recall.

getty

Federal health officials are advising parents to cease using Nara Organics Whole Milk Organic Infant Formula following its connection to a multistate infant botulism outbreak affecting three infants.

In a recent alert from the Centers for Disease Control and Prevention (CDC), it was reported that infants in California, Pennsylvania, and Washington contracted botulism after ingesting the formula. The affected infants, aged between two and five months, required hospitalization and received treatment with BabyBIG®, an FDA-approved remedy for infant botulism. Thankfully, no fatalities have occurred.

Nara Organics has initiated a recall of all its Whole Milk Organic Infant Formula products, covering all lot numbers and two can sizes available both online and at selected retailers nationwide. Ongoing investigations aim to identify the contamination source, with formula samples currently being tested. Results are anticipated in the coming weeks.

This recall follows a similar situation a few months prior, involving ByHeart infant formula, which was recalled on a national scale due to its links with botulism cases in infants. ByHeart’s formula was connected to 28 confirmed and 20 suspected cases across 17 states, with no fatalities reported. During the ByHeart recall, the company promoted Nara Organics as an alternative, offering a 20% discount coupon.

Infant botulism, a rare but severe illness, occurs when Clostridium botulinum spores enter an infant’s digestive system and produce toxins that attack nerves, causing muscle and respiratory paralysis. Infants under one year are particularly vulnerable due to their developing immune systems. Without treatment, the illness can lead to extensive muscle weakness and breathing difficulties, necessitating intensive medical care.

The CDC emphasizes that botulism symptoms can be delayed, taking several weeks to manifest. Parents are advised to monitor their infants for a month following the last exposure to the formula. Initial symptoms often include constipation, with potential feeding issues, poor sucking or swallowing, weak cry, reduced facial expressions, or loss of head control. Although uncommon, infant botulism can rapidly become life-threatening if not promptly addressed.

Consumers are advised by the CDC to either discard or return unopened cans of the recalled formula. Those with opened containers should document the lot number and use-by date and retain the remaining product for up to a month, should testing be required as part of an investigation. Officials suggest cleaning bottles, preparation surfaces, and related items using hot, soapy water or a dishwasher.

The CDC also reminds healthcare professionals that diagnosing infant botulism is primarily clinical. Experts recommend starting treatment as soon as the disease is suspected, without waiting for laboratory confirmation, as early intervention can significantly enhance patient outcomes.